Bios Capital Management, LP

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 9Value: $79.2MLatest: 2025Q1

BIOS Capital Management, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 9 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "INAB",
  null,
  "RNTX",
  "ACTU",
  "CGTX",
  "LTRN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 9
Total Value: 79177472
Accession Number: 0001104659-25-048606
Form Type: 13F-HR
CIK: bios-capital-management-lp
Manager Name: Bios-Capital-Management-Lp

Data Enrichment

89% identified

8 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

9 positions • $79.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

ACTUATE THERAPEUTICS, INC.

ACTU|005083100

Shares:9.9M

Value:$67.0M

% of Portfolio:84.6% ($67.0M/$79.2M)

Lantern Pharma Inc.

LTRN|51654W101

Shares:1.2M

Value:$4.3M

% of Portfolio:5.4% ($4.3M/$79.2M)

Rein Therapeutics, Inc.

RNTX|00887A204

Shares:1.7M

Value:$3.0M

% of Portfolio:3.8% ($3.0M/$79.2M)

COGNITION THERAPEUTICS INC

CGTX|19243B102

Shares:6.0M

Value:$2.5M

% of Portfolio:3.2% ($2.5M/$79.2M)

IN8BIO, INC.

INAB|45674E109

Shares:8.6M

Value:$1.4M

% of Portfolio:1.8% ($1.4M/$79.2M)

67577R102

Shares:995.2K

Value:$977.1K

% of Portfolio:1.2% ($977.1K/$79.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
ACTUATE THERAPEUTICS, INC.(ACTUcusip005083100)	9.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$67.0M	84.6% ($67.0M/$79.2M)	QoQ -14.94% (-$11.8M) YoY-
Lantern Pharma Inc.(LTRNcusip51654W101)	1.2M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$4.3M	5.4% ($4.3M/$79.2M)	QoQ +10.97% (+$422.7K) YoY-
Rein Therapeutics, Inc.(RNTXcusip00887A204)	1.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$3.0M	3.8% ($3.0M/$79.2M)	QoQ -23.04% (-$896.1K) YoY-
COGNITION THERAPEUTICS INC(CGTXcusip19243B102)	6.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$2.5M	3.2% ($2.5M/$79.2M)	QoQ -39.99% (-$1.7M) YoY-
IN8BIO, INC.(INABcusip45674E109)	8.6M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.4M	1.8% ($1.4M/$79.2M)	QoQ -35.45% (-$784.3K) YoY-
(cusip67577R102)✕	995.2K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$977.1K	1.2% ($977.1K/$79.2M)	QoQ -17.49% (-$207.2K) YoY-